Search Results - "Iglesias, Elizeth Garcia"

Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure by Fernández-Montequín, José I, Betancourt, Blas Y, Leyva-Gonzalez, Gisselle, Mola, Ernesto L, Galán-Naranjo, Katia, Ramírez-Navas, Mayte, Bermúdez-Rojas, Sergio, Rosales, Felix, García-Iglesias, Elizeth, Berlanga-Acosta, Jorge, Silva-Rodriguez, Ricardo, Garcia-Siverio, Marianela, Martinez, Luis H

“…Previous studies have shown that an epidermal growth factor‐based formulation (Heberprot‐P) can enhance granulation of high‐grade diabetic foot ulcers (DFU)…”
Get full text

Granulation Response and Partial Wound Closure Predict Healing in Clinical Trials on Advanced Diabetes Foot Ulcers Treated With Recombinant Human Epidermal Growth Factor by VALENZUELA-SILVA, Carmen M, TUERO-IGLESIAS, Angela D, GARCIA-IGLESIAS, Elizeth, GONZALEZ-DIAZ, Odalys, DEL RIO-MARTIN, Amaurys, BELKIS YERA ALOS, Isis, FERNANDEZ-MONTEQUIN, José I, LOPEZ-SAURA, Pedro A

“…To determine if partial wound closure surrogate markers proposed for neuropathic, small diabetic foot ulcers (DFUs) can be extended to advanced lesions and if…”
Get full text

Intralesional injections of Citoprot-P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation by Fernández-Montequín, José I, Infante-Cristiá, Ena, Valenzuela-Silva, Carmen, Franco-Pérez, Neobalis, Savigne-Gutierrez, William, Artaza-Sanz, Heriberto, Morejón-Vega, Lourdes, González-Benavides, Cecilio, Eliseo-Musenden, Osvaldo, García-Iglesias, Elizeth, Berlanga-Acosta, Jorge, Silva-Rodríguez, Ricardo, Betancourt, Blas Y, López-Saura, Pedro A

“…To investigate the efficacy and safety of recombinant human epidermal growth factor (rhEGF) in advanced diabetic foot ulcers (DFU) A double‐blind trial was…”
Get full text

Temporal trends of circulating nitric oxide and pro-inflammatory cytokine responses ex vivo in intra-abdominal sepsis: results from a cohort study by Ojeda Ojeda, Miriam, Larrondo Muguercia, Hilev, Magdariaga Figuerola, Abel, Sánchez Valdivia, Alfredo, Rodríguez Alonso, Ingrid, Valenzuela Silva, Carmen, García Iglesias, Elizeth, Domínguez Alonso, Emma, Buurman, Wim A, Araña Rosaínz, Manuel de Jesús

“…Objective and design To evaluate the association of pro-inflammatory mediators with organ dysfunction and adverse outcome in intra-abdominal sepsis patients…”
Get full text

Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG) in patients with mycosis fungoides: an open-label trial by García-Vega, Yanelda, García-García, Idrian, Collazo-Caballero, Sonia E, Santely-Pravia, Egla E, Cruz-Ramírez, Alieski, Tuero-Iglesias, Angela D, Alfonso-Alvarado, Cristian, Cabrera-Placeres, Mileidys, Castro-Basart, Nailet, Duncan-Roberts, Yaquelín, Carballo-Treto, Tania I, Soto-Matos, Josanne, Izquierdo-Toledo, Yoandy, Vázquez-Blomquist, Dania, García-Iglesias, Elizeth, Bello-Rivero, Iraldo

“…The synergistic combination of interferon (IFN) alpha-2b and IFN gamma results in more potent in vitro biological effects mediated by both IFNs. The aim of…”
Get full text

Phase I clinical trial of the (131)I-labeled anticarcinoembryonic antigen CIGB-M3 multivalent antibody fragment by González, Gilmara Pimentel, García, Idrian García, González, Joaquín González, Sánchez, Lincidio Pérez, Mirabal, Milagros Velasco, Marín, Carlos Calderón, Ruiz, Fausto L García, Iglesias, Elizeth Garcia, de Queralta, Rosalina López, Toirac, Ramón Ropero, Avila, Marta Ayala, Díaz, Adlín López, Saura, Pedro A López, Gavilondo, Jorge V, González, Juan P Oliva

“…Center for Genetic Engineering and Biotechnology (CIGB)-M3 is a trivalent recombinant single-chain Fv antibody fragment specific for carcinoembryonic antigen…”
Get more information

Aplicación Intralesional del Interferón alfa 2bHr cubano (Heberon Alfa R®) en el tratamiento de las verrugas genitales by Baladrón Castrillo, Idania, Barbón Gassó, Zaida, Solares Asteasuainzarra, Ana Margarita, Valenzuela Silva, Carmen, García Iglesias, Elizeth, Martínez Martínez-Pinillo, Angela

“…Introducción: la condilomatosis genital es la expresión clínica más frecuente de del virus del papiloma humano. De las alternativas de tratamiento existentes,…”
Get full text

Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction by Betancourt, Blas Y, Marrero-Miragaya, María A, Jiménez-López, Giset, Valenzuela-Silva, Carmen, García-Iglesias, Elizeth, Hernández-Bernal, Francisco, Debesa-García, Francisco, González-López, Tania, Alvarez-Falcón, Leovaldo, López-Saura, Pedro A

“…Streptokinase (SK) is an effective fibrinolytic agent for the treatment of acute myocardial infarction (AMI). The objective of the present study was to assess…”
Get full text

Interferon alpha-2b and ribavirin as combined therapy for chronic hepatitis C in Cuba: National Program by Hugo Nodarse-Cuní, Enrique Arús-Soler, Luis L Rivera-Reimón, Marlén Pérez-Lorenzo, Marcia Samada-Suárez, Waldo O García-Ferrera, Yoan A Sánchez-Rodríguez, Daymela Pupo-Oliveros, Angel Obregón-Moreno, Ivis Umpierre-García, Orelvis Martínez-Martínez, Antonio Moret-Pérez, Yaimé González-González, Yuliet Bermúdez-Hernández, Elizeth García-Iglesias, Odalys C Lazo-Diago, Pedro López-Saura

“…The treatment of chronic hepatitis C with interferon alpha (IFN-a) is widely used. However, the relapse rate is high, and sustained response is only in 10-20%…”
Get full text